College of Psychiatric and Neurologic Pharmacists

Sponsor: AstraZeneca
Title: What Goes Up Must Come Down: Recognition & Management of Bipolar Depression
Location: Mission Ballroom

Program Description: The recognition and treatment of bipolar depression can pose a great challenge for healthcare professionals. This interactive session will use audience response keypads to work through case studies. Topics will include the Mood Disorder Questionnaire (MDQ), a tool that healthcare professionals can administer in their clinical practice to assist with the recognition of bipolar depression, as well as an update on the role of neuroimaging in bipolar disorder.

Learning Objectives
At the completion of this program, the participant will use interactive case studies to:

• Apply the Mood Disorder Questionnaire (MDQ) to identify clinical symptomatology consistent with bipolar spectrum illnesses, including depressive symptoms.
• Recognize comorbidities that often confound accurate diagnosis of bipolar depression.
• Develop treatment strategies for management of bipolar depression that improve mood and outcomes without causing a switch into mania.
• Appropriately incorporate antidepressants in the treatment of bipolar depression.
• Outline developments in neuroimaging that may lead to improved diagnosis and treatment of bipolar depression.

Agenda

10:30 - 11:10 AM	Welcome & Introductions Treating Bipolar Depression: Where Are We Now? Matthew A. Fuller, PharmD, BCPP, BCPS, FASHP
11:10 - 11:50 AM	Treating Bipolar Depression: Looking Into the Future Contributions from Brain Imaging: Understanding the Pathophysiology of Bipolar Depression Jair C. Soares, MD
11:50 AM - 12:20 PM	Interactive Case Discussions Roger W. Sommi, PharmD, BCPP, FCCP
12:20 - 12:30 PM	Questions & Answers Faculty Panel
12:30 - 1:00 PM	Lunch

Faculty:

• Matthew A Fuller, PharmD, BCPP, BCPS, FASHP
  Associate Clinical Professor of Psychiatry
  Clinical Instructor of Psychology
  Case Western Reserve University
  Clinical Pharmacy Specialist in Psychiatry
  VA Medical Center
  Cleveland, Ohio
• Jair C. Soares, MD
  Associate Professor of Psychiatry and Radiology
  Krus Endowed Chair in Psychiatry
  Chief, Division of Mood and Anxiety Disorders
  University of Texas Health Science Center at San Antonio
  Department of Psychiatry
  Chief, VA Psychiatry Research
  South Texas Veterans Health Care System
  San Antonio, Texas
• Roger W. Sommi, PharmD, BCPP, FCCP
  Professor of Pharmacy Practice & Psychiatry
  University of Missouri-Kansas City
  School of Pharmacy
  Kansas City, Missouri

Accreditation:
Creative Educational Concepts, Inc. (CEC) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been assigned ACPE # 245-000-05-017-L01 and will award 2.0 contact hours (0.2 CEUs) of continuing education credit. CEC complies with the Criteria for Quality for continuing education programming. Statements of credit will be issued to those participants attending the program and completing a CE request form and will be mailed within 10 business days.

This activity has been planned and implemented in accordance with the Essentials and Standards for the Accreditation Council for Continuing Medical Education (ACCME). Creative Educational Concepts Foundation, Inc. (CEC Foundation) is accredited by the ACCME to provide continuing medical education for physicians. CEC Foundation designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity. Statements of credit will be issued within 10 business days.

Nurse Practitioners and Physician Assistants may be eligible to receive credit for completing AMA Category 1 activities from organizations accredited by the ACCME. If your state accepts AMA Category 1 credit, you are eligible to receive credit for this program.

Registration:
Please visit www.ceconcepts.net/cpnp for registration information.

Sponsor: Pfizer Inc.
Title: Innovations in Antipsychotic Pharmacotherapy (Dinner Program)

Learning Objectives:
At the conclusion of the program, participants should be able to:

• Compare and contrast the efficacy of atypical antipsychotic therapy in the treatment of schizophrenia and bipolar disorder
• Discuss critically the additional benefits of atypical antipsychotic therapy in schizophrenia achieved through improvements in neurocognition
• State the implications of atypical antipsychotic treatment choices for overall patient health outcomes

Description: Recent advances in the development of atypical antipsychotic therapy offer clinicians new options to improve outcomes in the treatment of schizophrenia and bipolar disorder. This symposium will compare atypical antipsychotic treatment choices associated with efficacy in positive and negative symptoms and discuss the importance of the neurocognitive effects and the implications of antipsychotic treatment choices for overall patient health outcomes.

Faculty:
Program Chair:

• Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP
  Chairman and Professor
  Department of Pharmacotherapy
  College of Pharmacy
  Washington State University
  Spokane, Washington

Guest Speakers:

• Michael Jann, PharmD, FCCP, FCP, BCPP
  Professor and Chair
  Clinical and Administrative Sciences Mercer University Southern School of Pharmacy Atlanta, Georgia
• Jonathan M. Meyer, MD
  Staff Psychiatrist VA San Diego Healthcare System Assistant Adjunct Professor of Psychiatry University of California, San Diego La Jolla, California

Speaker Titles:

• Expanding the Role of Atypical Antipsychotics in the Treatment of Psychotic and Non-Psychotic Disorders
  Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP
• Rapid Control and Long-Term Therapy: Atypical Antipsychotics in the Treatment of Bipolar Disorder
  Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP
• Beyond Efficacy: Implications of Atypical Antipsychotics and Neurocognitive Effects in Schizophrenia
  Michael W. Jann, PharmD, FCCP, FCP, BCPP
• Medical Considerations in Choosing Antipsychotic Treatments
  Jonathan M. Meyer, MD

ACPE: The University of Texas College of Pharmacy is approved by the American Council on Pharmaceutical Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 0.2 CEUs (2 contact hours) of continuing pharmaceutical education.

Sponsor: Bristol-Myers Squibb Company/Otsuka America Pharmaceutical, Inc.
Title: Pharmacotherapy of Bipolar and Other Psychotic Disorders: A Pathophysiologic Approach (Breakfast Program)
Location: The Hyatt Regency Islandia, Islands Room, San Diego, California

Description: Atypical antipsychotics are widely used as first-line therapy for the management of schizophrenia and, more recently, bipolar mania. Due to their therapeutic effects across a spectrum of psychiatric disorders, these agents are increasingly being used to treat a broad range of conditions in a variety of clinical settings. Since the atypical antipsychotics exhibit different pharmacologic profiles, clinically meaningful differences in effectiveness, (ie, efficacy in the real-world setting), tolerability and safety may impact overall patient health. This symposium will describe the expanding uses of atypical antipsychotics and how their different pharmacologic profiles may impact patient outcomes and influence choice of therapy.

Learning Objectives
Upon completion of this activity, participants should be better able to:

• Describe three approaches to the pharmacologic management of patients with acute mania
• Explain atypical antipsychotics and mood stabilizers with respect to their efficacy and short- and long-term safety and tolerability profiles
• Evaluate recent and ongoing clinical trial results in bipolar disorder and their impact on patient care

.
Faculty and Topics:

• Pharmacologic Management of the Acutely Manic Patient
  Roger Sommi, PharmD, BCCP
  Associate Professor
  University of Missouri - Kansas City
  School of Pharmacy
  Kansas City, Missouri
• Differential Pharmacology of Antipsychotic Agents in Bipolar Disorder
  Stephen R. Saklad, PharmD, BCCP
  Clinical Associate Professor
  Departments of Pharmacology and Psychiatry
  The University of Texas Health Science Center at San Antonio
  San Antonio, Texas
• Real-world Applications of Clinical Trials in Bipolar Disorder
  Michael J. Ostacher, MD, MPH
  Instructor, Harvard Medical School
  Harvard Bipolar Research Program
  Massachusetts General Hospital
  Boston, Massachusetts

Pharmacist Continuing Education

Accreditation Statement
The Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
The Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Program Number - 809-999-05-005-L01)

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be mailed to you within 3 weeks.

Registration
To register, please do one of the following:

• Phone: 877-783-7333
• Mail: send the completed form to SciMed LLC, 420 Lexington Ave, Suite 1420, New York, NY 10170
• Fax: 212-661-8338

Sponsor: Janssen Pharmaceutica
Title: "Out of the Shadow" Documentary Screening (Luncheon Program)

Description: This very personal documentary chronicles the filmmaker’s mother, Millie, and her family through Millie’s battle with schizophrenia, and her subsequent trials within the public health system.

Millie was just 25 with two small children when she was first plagued by the symptoms of schizophrenia. As mental chaos overwhelmed their mother, Susan and her sister Tina, struggled to cope with her. For years, the family's ignorance and shame kept Millie's behavior shrouded in a veil of secrecy. When her children left home, Millie life unraveled completely. Now, after 20 years of transience and inadequate care, Millie finally has a chance to reclaim her life.

A story of madness and dignity, shame and love, this intimate film illuminates a national plight through one family's struggle and helps dispel the stigmas and misconceptions surrounding this harrowing illness.

Praise for "Out of the Shadow":
"Out of the Shadow movingly captures a side of schizophrenia that few of us ever see, revealing the humility behind the disease without sentimentalizing it, and documenting the day-to-day injustices, tragedies and just plain frustrations experienced both by a woman who has schizophrenia and by those who love her."

"I showed your documentary to our mental health agency, and people loved it. It’s emotionally powerful and well balanced on many perspectives. It’s a realistic view of the pitfalls of the "system," the lengths families must go to, the ravages of illness and the prospects of recovery. Thank you for sharing this. Thank you even more for making it."

"This is a powerful and moving film that inspires whether or not you know anything about mental illness. I laughed, cried and was spellbound. Through the story of her mother’s fight with schizophrenia and her family’s struggle to not only survive, but to love, Susan Smiley brings new meaning to the word hope. Out of the Shadow is ultimately a story about a family that was torn apart by schizophrenia and unexpectedly healed by the making of this film."

"Ms. Smiley is unstinting in her honesty as she presents this very difficult and personal subject and that is what gives the film its forceful impact. Deserving of the widest possible audience, Out of the Shadow will clearly serve to inform the public and engage viewers about the challenges of coping with a mentally ill loved one. In addition, it will provide a wonderful training tool for all those in the mental health field, from students to practitioners."

"This is a remarkable film about schizophrenia, portraying one woman and her family’s experience with the illness. It is emotionally powerful, showing that recovery is possible, while at the same time exposing flaws in our mental healthcare system. Susan Smiley has produced a memorable, masterful work."

Guest: Susan is documentary producer, director and writer. After making documentaries for 7 years about other people, she was compelled to turn the camera on her own family. The result is Out of the Shadow, a powerful chronicle of her mother, who suffers from schizophrenia, over the course of 5 years. Susan has traveled world-wide exploring a wide range of subjects, including Ice Road Truckers which she directed, wrote and produced (and survived the Arctic winter) to Minesweepers about de-miners working in Bosnia. She produced Writers of the Future for Sci Fi Channel, and was CoProducer of numerous other films, including Drag Kings, Rescue Swimmers, Bounty Hunters, Miners, Volcanologists and The Monster That Ate Hollywood. Her projects have appeared on Discovery Channel, History Channel, Sci Fi Channel, MTV and FRONTLINE on PBS. She is currently working on a new film about youth in California’s juvenile justice system.

Pharmacist and Nursing Continuing Education
Accreditation Council for Pharmacy Education accreditation and nursing continuing education contact hours will not be available through this symposium.